Platelet-activating factor acetylhydrolase (PAF-AH). 2002

Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
Graduate School of Pharmaceutical Sciences, University of Tokyo, Hongo-Bunkyo-ku, Tokyo 113-0033, Japan. harai@mol.f.u-tokyo.ac.jp

Platelet-activating factor (PAF) is one of the most potent lipid messengers involved in a variety of physiological events. The acetyl group at the sn-2 position of its glycerol backbone is essential for its biological activity, and its deacetylation induces loss of activity. The deacetylation reaction is catalyzed by PAF-acetylhydrolase (PAF-AH). A series of biochemical and enzymological evaluations revealed that at least three types of PAF-AH exist in mammals, namely the intracellular types I and II and a plasma type. Type I PAF-AH is a G-protein-like complex consisting of two catalytic subunits (alpha1 and alpha2) and a regulatory beta subunit. The beta subunit is a product of the LIS1 gene, mutations of which cause type I lissencephaly. Recent studies indicate that LIS1/beta is important in cellular functions such as induction of nuclear movement and control of microtubule organization. Although substantial evidence is accumulating supporting the idea that the catalytic subunits are also involved in microtubule function, it is still unknown what role PAF plays in the process and whether PAF is an endogenous substrate of this enzyme. Type II PAF-AH is a single polypeptide and shows significant sequence homology with plasma PAF-AH. Type II PAF-AH is myristoylated at the N-terminus and like other N-myristoylated proteins is distributed in both the cytosol and membranes. Plasma PAF-AH is also a single polypeptide and exists in association with plasma lipoproteins. Type II PAF-AH as well as plasma PAF-AH may play a role as a scavenger of oxidized phospholipids which are thought to be involved in diverse pathological processes, including disorganization of membrane structure and PAF-like proinflammatory action. In this review, we will focus on the structures and possible biological functions of intracellular PAF-AHs.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008869 Microtubule-Associated Proteins High molecular weight proteins found in the MICROTUBULES of the cytoskeletal system. Under certain conditions they are required for TUBULIN assembly into the microtubules and stabilize the assembled microtubules. Ensconsin,Epithelial MAP, 115 kDa,Epithelial Microtubule-Associate Protein, 115 kDa,MAP4,Microtubule Associated Protein,Microtubule Associated Protein 4,Microtubule Associated Protein 7,Microtubule-Associated Protein,Microtubule-Associated Protein 7,E-MAP-115,MAP1 Microtubule-Associated Protein,MAP2 Microtubule-Associated Protein,MAP3 Microtubule-Associated Protein,Microtubule Associated Proteins,Microtubule-Associated Protein 1,Microtubule-Associated Protein 2,Microtubule-Associated Protein 3,7, Microtubule-Associated Protein,Associated Protein, Microtubule,E MAP 115,Epithelial Microtubule Associate Protein, 115 kDa,MAP1 Microtubule Associated Protein,MAP2 Microtubule Associated Protein,MAP3 Microtubule Associated Protein,Microtubule Associated Protein 1,Microtubule Associated Protein 2,Microtubule Associated Protein 3,Microtubule-Associated Protein, MAP1,Microtubule-Associated Protein, MAP2,Microtubule-Associated Protein, MAP3,Protein 7, Microtubule-Associated,Protein, Microtubule Associated,Protein, Microtubule-Associated
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D043203 1-Alkyl-2-acetylglycerophosphocholine Esterase A lipoprotein-associated PHOSPHOLIPASE A2 which modulates the action of PLATELET ACTIVATING FACTOR by hydrolyzing the SN-2 ester bond to yield the biologically inactive lyso-platelet-activating factor. It has specificity for phospholipid substrates with short-chain residues at the SN-2 position, but inactive against long-chain phospholipids. Deficiency in this enzyme is associated with many diseases including ASTHMA, and HYPERCHOLESTEROLEMIA. PAF Acetylhydrolase,Platelet-Activating Factor Hydrolase,Lipoprotein-Associated Phospholipase A(2),Lipoprotein-Associated Phospholipase A2,Lp-PLA(2),Lp-PLA2,PAF 2-Acetylhydrolase,PAF 2-Acylhydrolase,PAF Acetylhydrolase II,Platelet-activating Factor Acetylhydrolase IB,1 Alkyl 2 acetylglycerophosphocholine Esterase,2-Acetylhydrolase, PAF,Acetylhydrolase II, PAF,Acetylhydrolase, PAF,Esterase, 1-Alkyl-2-acetylglycerophosphocholine,Factor Hydrolase, Platelet-Activating,Hydrolase, Platelet-Activating Factor,Lipoprotein Associated Phospholipase A2,Lp PLA2,PAF 2 Acetylhydrolase,PAF 2 Acylhydrolase,Phospholipase A2, Lipoprotein-Associated,Platelet Activating Factor Hydrolase,Platelet activating Factor Acetylhydrolase IB
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic

Related Publications

Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
March 2003, Progress in lipid research,
Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
September 1994, The International journal of biochemistry,
Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
May 2008, Animal reproduction science,
Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
February 2009, Cardiovascular drugs and therapy,
Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
November 2008, Brain and nerve = Shinkei kenkyu no shinpo,
Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
April 2008, The New England journal of medicine,
Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
April 2008, The New England journal of medicine,
Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
April 2008, The New England journal of medicine,
Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
February 2007, Arquivos brasileiros de cardiologia,
Hiroyuki Arai, and Hiroyuki Koizumi, and Junken Aoki, and Keizo Inoue
October 2001, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!